In support of the contribution of fatty acyl-CoA hydrolysis, our current in vivo studies revealed that catalytically inactive N50A/D65A Them2 expression in skeletal muscle failed to recapture excess myosteatosis and hepatic steatosis along with glucose intolerance, insulin resistance, and reduced muscle uptake of circulating glucose. This evidence concerns the gene ACOT13 and fatty liver disease.